The fine tuning of the cells' “antitumorigenic” against “protumorigenic” phenotype is regulated in big part by TGF-β, subsequently involving a vast number of different cytokines, chemokines, and enzymes, all together defining the final direction of the tumor. Here, TGFB1 is linked to neoplasm.